Saturday 17 October 2026
Export RBOT’s income statement to Excel — free account
Vicarious Surgical Inc.
RBOT Healthcare Medical Devices
In the quarter to March 2026, EPS grew 60.4% and free cash flow grew 47.3%, each against the same quarter a year earlier.
0.02
0.06
−75.00%
Follow RBOT
Vicarious Surgical Inc. (RBOT) P/E ratio
Vicarious Surgical Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 112× (May 2022) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 112×
Ten-year median
0.0×
Current reading's percentile
84
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RBOT Vicarious Surgical Inc. | n/m |
| LFWD Lifeward Ltd. compare | n/m |
| BTCY Biotricity Inc. compare | n/m |
| SINT SINTX TECHNOLOGIES, INC. compare | n/m |
| ALUR Allurion Technologies, Inc. compare | n/m |
| IRIX IRIDEX Corporation compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| HSCS HeartSciences Inc. compare | n/m |
| PETV PetVivo Holdings, Inc. compare | n/m |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)